This work showed that tau-SAA analysis of skin biopsies is feasible and distinguishes living patients with tauopathies from those with synucleinopathies and HC with 73% sensitivity and 93% specificity in concordance with the clinical diagnosis. Here, MAPT is linked to synucleinopathy.